| 73 4.88 (7.16%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 87.54  |
1-year : | 102.24 |
| Resists | First : | 74.94 |
Second : | 87.54 |
| Pivot price | 63.43 |
|||
| Supports | First : | 62.89 |
Second : | 55.43 |
| MAs | MA(5) : | 66.56 |
MA(20) : | 62.3 |
| MA(100) : | 51.04 |
MA(250) : | 68.64  |
|
| MACD | MACD : | 3.2 |
Signal : | 2.5 |
| %K %D | K(14,3) : | 90.3 |
D(3) : | 85.4 |
| RSI | RSI(14): 76.1 |
|||
| 52-week | High : | 147.02 | Low : | 38.9 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ INSP ] has closed above the upper band by 24.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 32.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 75.04 - 75.33 | 75.33 - 75.62 |
| Low: | 69.14 - 69.48 | 69.48 - 69.81 |
| Close: | 72.45 - 72.97 | 72.97 - 73.49 |
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Sat, 12 Sep 2026
Why Inspire Medical Systems (INSP) Stock Is Up Today - Yahoo Finance
Fri, 11 Sep 2026
Inspire Medical Systems Inc (INSP) Stock Up 7.2% and Still Undervalued -- GF Score: 58/100 - GuruFocus
Fri, 11 Sep 2026
Inspire Medical Systems Jumps 8.7% Amid Sector-Wide Rally - AlphaStreet
Wed, 09 Sep 2026
INSP: Coding clarity, Inspire V outcomes, and Project Horizon set stage for renewed growth - tradingview.com
Mon, 07 Sep 2026
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Growth Potential with a 17.97% Return on Equity - DirectorsTalk Interviews
Wed, 02 Sep 2026
Inspire Medical (INSP) awards 6,350 RSUs vesting over 3 years - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 29 (M) |
| Shares Float | 23 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 130.4 (%) |
| Shares Short | 4,370 (K) |
| Shares Short P.Month | 4,340 (K) |
| EPS | 4.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 28.55 |
| Profit Margin | 15 % |
| Operating Margin | -0.3 % |
| Return on Assets (ttm) | 3.9 % |
| Return on Equity (ttm) | 17.9 % |
| Qtrly Rev. Growth | -7.6 % |
| Gross Profit (p.s.) | 26.77 |
| Sales Per Share | 31.08 |
| EBITDA (p.s.) | 2.46 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 157 (M) |
| Levered Free Cash Flow | 95 (M) |
| PE Ratio | 16.11 |
| PEG Ratio | 0 |
| Price to Book value | 2.55 |
| Price to Sales | 2.34 |
| Price to Cash Flow | 13.43 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|